Fitchett D, Pathe M, Pardy R, Despas P
Br Heart J. 1980; 44(2):215-20.
PMID: 7426176
PMC: 482385.
DOI: 10.1136/hrt.44.2.215.
Clark A, MCMICHAEL H
Postgrad Med J. 1981; 57(671):602-3.
PMID: 7329902
PMC: 2426154.
DOI: 10.1136/pgmj.57.671.602.
Drexler H, Lollgen H, Just H
Klin Wochenschr. 1981; 59(12):647-54.
PMID: 7253539
DOI: 10.1007/BF02593856.
Massie B, Kramer B, Shen E, Haughom F
Br Heart J. 1981; 45(4):376-84.
PMID: 7225252
PMC: 482537.
DOI: 10.1136/hrt.45.4.376.
Al-Damluji S, Nathan A, Johnston A, Banim S, Spurrell R, Camm A
Postgrad Med J. 1982; 58(678):216-21.
PMID: 7111101
PMC: 2426383.
DOI: 10.1136/pgmj.58.678.216.
Clinical and haemodynamic responses to captopril and hydralazine in chronic congestive heart failure: the importance of preload reduction.
Fitzgerald D, OCallaghan W, OMalley K, Horgan J, OBrien E
Br J Clin Pharmacol. 1982; 14 Suppl 2:217S-222S.
PMID: 6753903
PMC: 1427535.
DOI: 10.1111/j.1365-2125.1982.tb02080.x.
Acute and long-term effects of captopril on exercise cardiac performance and exercise capacity in congestive heart failure.
Kramer B, Topic N, Massie B
Br J Clin Pharmacol. 1982; 14 Suppl 2:143S-151S.
PMID: 6753895
PMC: 1427515.
DOI: 10.1111/j.1365-2125.1982.tb02071.x.
Vasodilator therapy in chronic congestive heart failure.
Schwartz A, Chatterjee K
Drugs. 1983; 26(2):148-73.
PMID: 6349967
DOI: 10.2165/00003495-198326020-00003.
Recent advances in cardiology.
Rodrigues E, Coltart D
Postgrad Med J. 1982; 58(682):459-66.
PMID: 6215639
PMC: 2426532.
DOI: 10.1136/pgmj.58.682.459.
Symptoms, haemodynamics, and exercise capacity during long term treatment of chronic heart failure. Experience with pirbuterol.
Dawson J, Canepa-Anson R, Kuan P, Reuben S, Poole-Wilson P, Sutton G
Br Heart J. 1983; 50(3):282-9.
PMID: 6137226
PMC: 481410.
DOI: 10.1136/hrt.50.3.282.
The frontiers of cardiomyopathy.
Goodwin J
Br Heart J. 1982; 48(1):1-18.
PMID: 6123334
PMC: 481195.
DOI: 10.1136/hrt.48.1.1.
Abnormalities of the peripheral circulation and respiratory function in patients with severe heart failure.
Cowley A, Stainer K, Rowley J, Hampton J
Br Heart J. 1986; 55(1):75-80.
PMID: 3947485
PMC: 1232071.
DOI: 10.1136/hrt.55.1.75.
Acute haemodynamic effects of felodipine in congestive heart failure.
Emanuelsson H, Hjalmarson A, Holmberg S, Waagstein F
Eur J Clin Pharmacol. 1985; 28(5):489-93.
PMID: 3899668
DOI: 10.1007/BF00544056.
The treatment of heart failure. A methodological review of the literature.
Guyatt G
Drugs. 1986; 32(6):538-68.
PMID: 3024949
DOI: 10.2165/00003495-198632060-00004.
Vasodilator therapy without converting-enzyme inhibition in congestive heart failure--usefulness and limitations.
Remme W
Cardiovasc Drugs Ther. 1989; 3(3):375-96.
PMID: 2487535
DOI: 10.1007/BF01858109.
Which vasodilator drug in patients with chronic heart failure? A randomised comparison of captopril and hydralazine.
Schofield P, Brooks N, Lawrence G, Testa H, Ward C
Br J Clin Pharmacol. 1991; 31(1):25-32.
PMID: 2015167
PMC: 1368408.
DOI: 10.1111/j.1365-2125.1991.tb03853.x.
